Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
The continued spread of the H5N1 influenza virus emphasizes the importance of anti-influenza immune defense mechanisms. Three papers in this month's issue of Nature Immunology examine the immune cell response to influenza virus infection and discuss the challenge this virus poses to population-based immunity (pp 443, 449 and 517). Image shows an agglomeration of influenza viruses. Artwork by Lewis Long.
Immunology had an unexpected and decisive part in challenging the claims of 'Intelligent Design' proponents at the US trial on the teaching of evolution in public schools in Dover, Pennsylvania.
Contact hypersensitivity is a form of delayed-type hypersensitivity, a classic T cell–mediated, clinically important phenomenon. Unexpectedly, a new study indicates that natural killer cells may mediate contact hypersensitivity and demonstrate adaptive, memory-like activity.
The resolution of immune responses typically leaves a population of memory T cells to respond to subsequent infection. The generation of 'memory-like' T cells can also occur during homeostatic proliferation, but are they 'true' memory cells?
Plasmacytoid dendritic cells selectively express Toll-like receptors 7 and 9 and respond to virus infection by triggering massive interferon production, a pathway regulated by osteopontin expressed in plasmacytoid dendritic cells.
NKp46, an activating receptor expressed on natural killer cells, protects from lethal influenza virus infection. Contrary to prevailing views, involvement of NKp46 in tumor immunity is uncertain.
B lymphocyte–induced maturation protein 1 (Blimp-1) is known as a 'master regulator' of plasma cell differentiation. New findings suggest that the influence of this transcription factor extends beyond the B cell lineage.